|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,470.00 KRW | +4.59% |
|
+18.91% | -19.79% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.59% | +18.91% | +20.88% | -26.38% | -19.79% | -32.22% | - | - | - | 87.76M | |
| -1.16% | +17.75% | +17.93% | +63.90% | +38.96% | +109.51% | +496.83% | +201.27% | +2,955.18% | 46.43B | |
| +0.67% | +4.52% | +16.08% | +26.44% | +28.07% | +20.86% | +50.13% | +6.52% | +129.26% | 25.88B | |
| +0.27% | +2.47% | +4.87% | +18.27% | -0.93% | -19.02% | -34.52% | -45.10% | +2.80% | 7.76B | |
| +6.76% | +15.69% | +17.80% | +32.81% | +8.31% | +44.83% | +142.18% | +129.52% | +1,140.45% | 5.69B | |
| +1.16% | +2.56% | +15.99% | +18.44% | +31.80% | +22.50% | +63.98% | +0.48% | +328.81% | 3.39B | |
| +1.04% | +14.77% | +18.65% | +91.02% | -40.12% | -25.92% | +1,363.91% | -80.72% | - | 2.3B | |
| +0.36% | +4.99% | +17.86% | +85.60% | +41.41% | +186.72% | +17.90% | -60.69% | +106.58% | 2.13B | |
| +6.83% | +11.49% | +35.21% | +10.02% | +9.13% | +2.48% | -53.01% | -77.24% | - | 1.99B | |
| +4.04% | +15.84% | +15.27% | +0.24% | +33.38% | +33.80% | -8.80% | -39.46% | -32.72% | 1.84B | |
| +3.07% | +3.59% | +1.07% | +8.89% | +31.25% | +32.08% | +185.31% | - | - | 1.46B | |
| +1.76% | +3.66% | +5.65% | +13.26% | +4.55% | +9.71% | +38.29% | +22.31% | -30.39% | 1.21B | |
| +1.46% | +6.11% | +2.96% | +21.93% | +10.32% | +11.20% | -23.63% | -62.43% | -85.99% | 1.02B | |
| +2.99% | +7.33% | +16.30% | +28.05% | +39.37% | +39.86% | +226.21% | +38.75% | +237.15% | 1.01B | |
| +2.22% | +19.42% | +19.51% | +0.46% | +14.38% | -5.53% | -34.86% | -75.73% | - | 892M | |
| -0.42% | -0.28% | -2.32% | -6.54% | -7.38% | +2.73% | +21.81% | -10.51% | +46.22% | 853M | |
| +0.94% | +1.43% | +2.40% | -6.17% | -16.14% | -22.83% | -29.47% | -59.96% | +26.04% | 574M | |
| +5.39% | +13.68% | +18.55% | -8.62% | +7.78% | -6.91% | -37.77% | - | - | 559M | |
| +3.83% | +26.12% | +4.10% | -7.84% | -5.82% | +27.50% | +21.06% | - | - | 553M | |
| -0.42% | +8.23% | -7.25% | +19.42% | -27.45% | -6.39% | -41.39% | -80.42% | - | 527M | |
| Average | +2.13% | +7.16% | +12.08% | +19.16% | +9.05% | +21.25% | +124.43% | -12.09% | +401.95% | 5.31B | |
| Weighted average by Cap. | +0.49% | +9.60% | +15.79% | +42.61% | +26.78% | +59.46% | +269.95% | +88.98% | +1,518.57% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions
